{"id":169887,"date":"2024-07-23T02:43:24","date_gmt":"2024-07-23T06:43:24","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/transcode-therapeutics-inc-announces-proposed-public-offering-of-common-stock\/"},"modified":"2024-08-18T11:48:42","modified_gmt":"2024-08-18T15:48:42","slug":"transcode-therapeutics-inc-announces-proposed-public-offering-of-common-stock","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/transcode-therapeutics-inc-announces-proposed-public-offering-of-common-stock.php","title":{"rendered":"TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock"},"content":{"rendered":"<p><![CDATA[BOSTON, July  22, 2024  (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (\u201cTransCode\u201d or the \u201cCompany\u201d), a clinical-stage RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it intends to offer to sell shares of its common stock (and\/or pre-funded warrants (\u201cPre-funded Warrants\u201d) in lieu thereof) in a best efforts public offering. All of the shares of common stock (and\/or Pre-funded Warrants) are to be sold by the Company.]]><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/07\/22\/2916837\/0\/en\/TransCode-Therapeutics-Inc-Announces-Proposed-Public-Offering-of-Common-Stock.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock\">TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post: TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/transcode-therapeutics-inc-announces-proposed-public-offering-of-common-stock.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-169887","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169887"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=169887"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169887\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=169887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=169887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=169887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}